Abiopharma

🔍 Hammond Karen (Director)

Company: TWO HARBORS INVESTMENT CORP. (TWO)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Sold 59,097 shares of Common stock, par value $0.01 per share at $12.0 per share (Direct)
  Date: 2026-08-25 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Pursuant to the Agreement and Plan of Merger, dated March 27, 2026, by and among Two Harbors Investment Corp. ("TWO"), CrossCountry Intermediate Holdco, LLC ("CCM") and CrossCountry Merger Corp., a wholly owned subsidiary of CCM ("Merger Sub"), as amended, Merger Sub merged with and into TWO, with TWO surviving the merger as a wholly owned subsidiary of CCM (the "CCM Merger"). At the effective time of the CCM Merger (the "Effective Time"), each share of TWO's common stock that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $12.00 in cash.